Status:
UNKNOWN
Cardiac Magnetic Resonance for Early Detection of Chemotherapy or Radiation Therapy Induced Cardiotoxicity in Breast Cancer (CareBest)
Lead Sponsor:
Yonsei University
Conditions:
Chemotherapy Induced Cardiotoxicity
Eligibility:
FEMALE
17-80 years
Brief Summary
Chemotherapy or radiation therapy-induced cardiotoxicity are well-recognized side effects in patients with cancer. The clinical significance of cardiotoxicity is growing with increasing cancer survivo...
Detailed Description
Screening and follow-up cardiac magnetic resonance imaging (CMR) protocols for diagnosis of cardiotoxicity will be conducted in patients with breast cancer who have received or are planned to receive ...
Eligibility Criteria
Inclusion
- Patient with breast cancer
Exclusion
- Contraindication of MRI
- Failure with informed consent
- Fail to scan screening protocol
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03301389
Start Date
December 1 2016
End Date
January 1 2025
Last Update
January 11 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea, 03722